{"id": "b48hf1", "title": "FDA does not approve LXRX's diabetes drug (sotagliflozin)", "selftext": "[FDA Issues Complete Response Letter for Zynquista\u2122 (sotagliflozin)](https://www.globenewswire.com/news-release/2019/03/22/1759501/0/en/FDA-Issues-Complete-Response-Letter-for-Zynquista-sotagliflozin.html)", "created_utc": 1553278851, "permalink": "/r/wallstreetbets/comments/b48hf1/fda_does_not_approve_lxrxs_diabetes_drug/", "is_self": true}